Sun A M, Kikeri D, Hebert S C
Harvard Center for the Study of Kidney Disease, Harvard Medical School, Boston, Massachusetts.
Am J Physiol. 1992 Feb;262(2 Pt 2):F241-7. doi: 10.1152/ajprenal.1992.262.2.F241.
We assessed in isolated perfused mouse medullary thick ascending limb (MTAL) segments Na(+)-H+ antiporter activity in both apical and basolateral membranes and the effects of arginine vasopressin (AVP) on the activities of these antiporters under isotonic conditions using 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein to monitor intracellular pH (pHi). When the apical Na(+)-H+ antiporter was inhibited in the absence of AVP with removal of luminal Na+ plus addition of 0.5 mM amiloride, a small but significant increase in pHi was observed after luminal NH4Cl-induced acidification of MTAL cells to pHi less than 6.7. This increase in pHi was dependent on basolateral Na+ and inhibited with 0.5 mM basolateral amiloride, consistent with the function of a basolateral Na(+)-H+ antiporter. Basolateral AVP (100 microU/ml) enhanced the rate of pHi recovery due to the basolateral Na(+)-H+ antiporter by more than twofold. In contrast, AVP decreased the apical Na(+)-H+ antiporter activity by 50%. In the absence of AVP, addition of 0.5 mM amiloride to the luminal perfusate reduced steady-state pHi by 0.40 +/- 0.07 units, whereas exposure of the basolateral membrane to the same concentration of amiloride had no effect on pHi (delta pHi = 0.01 +/- 0.01 units). AVP reduced the magnitude of cell acidification on exposure of apical membranes to amiloride (delta pHi = 0.16 +/- 0.03) but increased the pHi response to basolateral amiloride (delta pHi = 0.09 +/- 0.00). Thus Na(+)-H+ antiporters are present on both apical and basolateral membranes of the mouse MTAL in the absence of AVP. AVP stimulates the basolateral, while inhibiting the apical, Na(+)-H+ antiporter.(ABSTRACT TRUNCATED AT 250 WORDS)
我们在等渗条件下,使用2',7'-双(羧乙基)-5(6)-羧基荧光素监测细胞内pH值(pHi),评估了分离灌注的小鼠髓袢升支粗段(MTAL)顶端和基底外侧膜上的Na(+)-H+逆向转运体活性,以及精氨酸加压素(AVP)对这些逆向转运体活性的影响。在无AVP的情况下,通过去除管腔Na+并添加0.5 mM氨氯吡脒抑制顶端Na(+)-H+逆向转运体,当管腔NH4Cl将MTAL细胞酸化至pHi小于6.7后,观察到pHi有小幅但显著的升高。pHi的这种升高依赖于基底外侧Na+,并被0.5 mM基底外侧氨氯吡脒抑制,这与基底外侧Na(+)-H+逆向转运体的功能一致。基底外侧AVP(100微单位/毫升)使基底外侧Na(+)-H+逆向转运体导致的pHi恢复速率提高了两倍多。相反,AVP使顶端Na(+)-H+逆向转运体活性降低了50%。在无AVP的情况下,向管腔灌注液中添加0.5 mM氨氯吡脒使稳态pHi降低0.40±0.07单位,而将基底外侧膜暴露于相同浓度的氨氯吡脒对pHi无影响(pHi变化=0.01±0.01单位)。AVP降低了顶端膜暴露于氨氯吡脒时细胞酸化的幅度(pHi变化=0.16±0.03),但增加了对基底外侧氨氯吡脒的pHi反应(pHi变化=0.09±0.00)。因此,在无AVP的情况下,小鼠MTAL的顶端和基底外侧膜上均存在Na(+)-H+逆向转运体。AVP刺激基底外侧Na(+)-H+逆向转运体,同时抑制顶端Na(+)-H+逆向转运体。(摘要截短于250字)